The functional role of L-fucose on dendritic cell function and polarization.

L-fucose antigen presentation dendritic cells myeloid cells tumor immune microenvironment

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 10 12 2023
accepted: 21 02 2024
medline: 22 4 2024
pubmed: 22 4 2024
entrez: 22 4 2024
Statut: epublish

Résumé

Despite significant advances in the development and refinement of immunotherapies administered to combat cancer over the past decades, a number of barriers continue to limit their efficacy. One significant clinical barrier is the inability to mount initial immune responses towards the tumor. As dendritic cells are central initiators of immune responses in the body, the elucidation of mechanisms that can be therapeutically leveraged to enhance their functions to drive anti-tumor immune responses is urgently needed. Here, we report that the dietary sugar L-fucose can be used to enhance the immunostimulatory activity of dendritic cells (DCs). L-fucose polarizes immature myeloid cells towards specific DC subsets, specifically cDC1 and moDC subsets.

Identifiants

pubmed: 38646527
doi: 10.3389/fimmu.2024.1353570
pmc: PMC11026564
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1353570

Informations de copyright

Copyright © 2024 Burton, Bitaraf, Snyder, Zhang, Yoder, Avram, Du, Yu and Lau.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Chase Burton (C)

Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.
Cancer Biology Ph.D. Program, University of South Florida, Tampa, FL, United States.
Immunology Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.

Amirreza Bitaraf (A)

Cancer Biology Ph.D. Program, University of South Florida, Tampa, FL, United States.
Molecular Medicine Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.
Department of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.

Kara Snyder (K)

Molecular Medicine Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.
Department of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.
Department of Molecular Medicine, University of South Florida, Tampa, FL, United States.

Chaomei Zhang (C)

Molecular Genomics Core, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.

Sean J Yoder (SJ)

Molecular Genomics Core, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.

Dorina Avram (D)

Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.
Immunology Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.

Dongliang Du (D)

Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.

Xiaoqing Yu (X)

Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.

Eric K Lau (EK)

Molecular Medicine Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.
Department of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.

Classifications MeSH